This comprehensive report provides a detailed analysis of the global AFB1 ELISA Kit market, forecasting its growth trajectory from 2025 through 2032. The study examines key market dynamics, including drivers and emerging trends, while segmenting the industry by type, application, and major geographic regions such as the Americas, APAC, and Europe. By profiling leading players like Elabscience Biotechnology and Abcam, the report highlights competitive landscapes, strategic developments, and significant opportunities across various research and clinical sectors.

Market Overview

The global AFB1 ELISA Kit market is projected to experience significant growth from 2025 through 2032, maintaining a steady compound annual growth rate throughout the forecast period.

Regional Market Projections

• United States: The market for AFB1 ELISA Kits in the United States is estimated to increase steadily from 2025 through 2032.
• China: The Chinese market for AFB1 ELISA Kits is expected to see upward growth between 2025 and 2032.
• Europe: The European market for AFB1 ELISA Kits is projected to expand over the period from 2025 to 2032.

Report Scope and Methodology

LP Information, Inc. (LPI)’s newest research report, the “AFB1 ELISA Kit Industry Forecast,” provides a comprehensive analysis of the global landscape. The report reviews total world AFB1 ELISA Kit sales in 2025 and provides a detailed analysis of projected sales for 2026 through 2032, broken down by region, market sector, and sub-sector in US$ millions.

This Insight Report evaluates key market trends, drivers, and affecting factors shaping the global outlook. It highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

The report also analyzes the strategies of leading global companies, focusing on their AFB1 ELISA Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating global market. The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the industry.

Market Segmentation

By Type

• Human
• Mouse
• Rat
• Other

By Application

• Hospital
• Research Institute
• Other

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

The global AFB1 ELISA Kit market features several key players. In 2025, the two largest companies held a significant portion of the total market revenue share. The companies profiled in this report were selected based on primary expert input and analysis of their coverage, product portfolio, and market penetration.

Key Players

• Elabscience Biotechnology Inc.
• LifeSpan BioSciences, Inc
• Creative Diagnostics
• Abcam
• Biomatik
• CLOUD-CLONE CORP.
• Innovative Research
• Abnova
• Abbexa
• Assay Genie
• Boster Biological Technology
• ScienCell Research Laboratories
• Arigo Biolaboratories Corp.
• RayBiotech, Inc.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global AFB1 ELISA Kit Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for AFB1 ELISA Kit by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for AFB1 ELISA Kit by Country/Region, 2021, 2025 & 2032

  • 2.2 AFB1 ELISA Kit Segment by Type

    • 2.2.1 Human

    • 2.2.2 Mouse

    • 2.2.3 Rat

    • 2.2.4 Other

    • 2.2.5 AFB1 ELISA Kit Sales by Type

      • 2.2.5.1 Global AFB1 ELISA Kit Sales Market Share by Type (2021-2026)
      • 2.2.5.2 Global AFB1 ELISA Kit Revenue and Market Share by Type (2021-2026)
      • 2.2.5.3 Global AFB1 ELISA Kit Sale Price by Type (2021-2026)

  • 2.3 AFB1 ELISA Kit Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Research Institute

    • 2.3.3 Other

    • 2.3.4 AFB1 ELISA Kit Sales by Application

      • 2.3.4.1 Global AFB1 ELISA Kit Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global AFB1 ELISA Kit Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global AFB1 ELISA Kit Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global AFB1 ELISA Kit Breakdown Data by Company

    • 3.1.1 Global AFB1 ELISA Kit Annual Sales by Company (2021-2026)

    • 3.1.2 Global AFB1 ELISA Kit Sales Market Share by Company (2021-2026)

  • 3.2 Global AFB1 ELISA Kit Annual Revenue by Company (2021-2026)

    • 3.2.1 Global AFB1 ELISA Kit Revenue by Company (2021-2026)

    • 3.2.2 Global AFB1 ELISA Kit Revenue Market Share by Company (2021-2026)

  • 3.3 Global AFB1 ELISA Kit Sale Price by Company

  • 3.4 Key Manufacturers AFB1 ELISA Kit Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers AFB1 ELISA Kit Product Location Distribution

    • 3.4.2 Players AFB1 ELISA Kit Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for AFB1 ELISA Kit by Geographic Region

  • 4.1 World Historic AFB1 ELISA Kit Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global AFB1 ELISA Kit Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global AFB1 ELISA Kit Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic AFB1 ELISA Kit Market Size by Country/Region (2021-2026)

    • 4.2.1 Global AFB1 ELISA Kit Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global AFB1 ELISA Kit Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas AFB1 ELISA Kit Sales Growth

  • 4.4 APAC AFB1 ELISA Kit Sales Growth

  • 4.5 Europe AFB1 ELISA Kit Sales Growth

  • 4.6 Middle East & Africa AFB1 ELISA Kit Sales Growth

• 5 Americas

  • 5.1 Americas AFB1 ELISA Kit Sales by Country

    • 5.1.1 Americas AFB1 ELISA Kit Sales by Country (2021-2026)

    • 5.1.2 Americas AFB1 ELISA Kit Revenue by Country (2021-2026)

  • 5.2 Americas AFB1 ELISA Kit Sales by Type (2021-2026)

  • 5.3 Americas AFB1 ELISA Kit Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC AFB1 ELISA Kit Sales by Region

    • 6.1.1 APAC AFB1 ELISA Kit Sales by Region (2021-2026)

    • 6.1.2 APAC AFB1 ELISA Kit Revenue by Region (2021-2026)

  • 6.2 APAC AFB1 ELISA Kit Sales by Type (2021-2026)

  • 6.3 APAC AFB1 ELISA Kit Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe AFB1 ELISA Kit by Country

    • 7.1.1 Europe AFB1 ELISA Kit Sales by Country (2021-2026)

    • 7.1.2 Europe AFB1 ELISA Kit Revenue by Country (2021-2026)

  • 7.2 Europe AFB1 ELISA Kit Sales by Type (2021-2026)

  • 7.3 Europe AFB1 ELISA Kit Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa AFB1 ELISA Kit by Country

    • 8.1.1 Middle East & Africa AFB1 ELISA Kit Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa AFB1 ELISA Kit Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa AFB1 ELISA Kit Sales by Type (2021-2026)

  • 8.3 Middle East & Africa AFB1 ELISA Kit Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of AFB1 ELISA Kit

  • 10.3 Manufacturing Process Analysis of AFB1 ELISA Kit

  • 10.4 Industry Chain Structure of AFB1 ELISA Kit

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 AFB1 ELISA Kit Distributors

  • 11.3 AFB1 ELISA Kit Customer

• 12 World Forecast Review for AFB1 ELISA Kit by Geographic Region

  • 12.1 Global AFB1 ELISA Kit Market Size Forecast by Region

    • 12.1.1 Global AFB1 ELISA Kit Forecast by Region (2027-2032)

    • 12.1.2 Global AFB1 ELISA Kit Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global AFB1 ELISA Kit Forecast by Type (2027-2032)

  • 12.7 Global AFB1 ELISA Kit Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Elabscience Biotechnology Inc.

    • 13.1.1 Elabscience Biotechnology Inc. Company Information

    • 13.1.2 Elabscience Biotechnology Inc. AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.1.3 Elabscience Biotechnology Inc. AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Elabscience Biotechnology Inc. Main Business Overview

    • 13.1.5 Elabscience Biotechnology Inc. Latest Developments

  • 13.2 LifeSpan BioSciences, Inc

    • 13.2.1 LifeSpan BioSciences, Inc Company Information

    • 13.2.2 LifeSpan BioSciences, Inc AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.2.3 LifeSpan BioSciences, Inc AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 LifeSpan BioSciences, Inc Main Business Overview

    • 13.2.5 LifeSpan BioSciences, Inc Latest Developments

  • 13.3 Creative Diagnostics

    • 13.3.1 Creative Diagnostics Company Information

    • 13.3.2 Creative Diagnostics AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.3.3 Creative Diagnostics AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Creative Diagnostics Main Business Overview

    • 13.3.5 Creative Diagnostics Latest Developments

  • 13.4 Abcam

    • 13.4.1 Abcam Company Information

    • 13.4.2 Abcam AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.4.3 Abcam AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Abcam Main Business Overview

    • 13.4.5 Abcam Latest Developments

  • 13.5 Biomatik

    • 13.5.1 Biomatik Company Information

    • 13.5.2 Biomatik AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.5.3 Biomatik AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Biomatik Main Business Overview

    • 13.5.5 Biomatik Latest Developments

  • 13.6 CLOUD-CLONE CORP.

    • 13.6.1 CLOUD-CLONE CORP. Company Information

    • 13.6.2 CLOUD-CLONE CORP. AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.6.3 CLOUD-CLONE CORP. AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 CLOUD-CLONE CORP. Main Business Overview

    • 13.6.5 CLOUD-CLONE CORP. Latest Developments

  • 13.7 Innovative Research

    • 13.7.1 Innovative Research Company Information

    • 13.7.2 Innovative Research AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.7.3 Innovative Research AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Innovative Research Main Business Overview

    • 13.7.5 Innovative Research Latest Developments

  • 13.8 Abnova

    • 13.8.1 Abnova Company Information

    • 13.8.2 Abnova AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.8.3 Abnova AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Abnova Main Business Overview

    • 13.8.5 Abnova Latest Developments

  • 13.9 Abbexa

    • 13.9.1 Abbexa Company Information

    • 13.9.2 Abbexa AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.9.3 Abbexa AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Abbexa Main Business Overview

    • 13.9.5 Abbexa Latest Developments

  • 13.10 Assay Genie

    • 13.10.1 Assay Genie Company Information

    • 13.10.2 Assay Genie AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.10.3 Assay Genie AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Assay Genie Main Business Overview

    • 13.10.5 Assay Genie Latest Developments

  • 13.11 Boster Biological Technology

    • 13.11.1 Boster Biological Technology Company Information

    • 13.11.2 Boster Biological Technology AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.11.3 Boster Biological Technology AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Boster Biological Technology Main Business Overview

    • 13.11.5 Boster Biological Technology Latest Developments

  • 13.12 ScienCell Research Laboratories

    • 13.12.1 ScienCell Research Laboratories Company Information

    • 13.12.2 ScienCell Research Laboratories AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.12.3 ScienCell Research Laboratories AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 ScienCell Research Laboratories Main Business Overview

    • 13.12.5 ScienCell Research Laboratories Latest Developments

  • 13.13 Arigo Biolaboratories Corp.

    • 13.13.1 Arigo Biolaboratories Corp. Company Information

    • 13.13.2 Arigo Biolaboratories Corp. AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.13.3 Arigo Biolaboratories Corp. AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 Arigo Biolaboratories Corp. Main Business Overview

    • 13.13.5 Arigo Biolaboratories Corp. Latest Developments

  • 13.14 RayBiotech, Inc.

    • 13.14.1 RayBiotech, Inc. Company Information

    • 13.14.2 RayBiotech, Inc. AFB1 ELISA Kit Product Portfolios and Specifications

    • 13.14.3 RayBiotech, Inc. AFB1 ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 RayBiotech, Inc. Main Business Overview

    • 13.14.5 RayBiotech, Inc. Latest Developments

• 14 Research Findings and Conclusion